Awareness and use of generative AI-powered tools: results of one-year follow-up prospective cross-sectional global survey.

Journal: Minerva urology and nephrology
Published Date:

Abstract

BACKGROUND: Generative AI (GenAI) frameworks, such as generative pre-trained transformer (GPTs) and large language models (LLMs), promise to transform clinical and research practices. Informed human opinion is key to guiding appropriate technological development and task refinement. Detailed data on how GPTs/LLMs powered-Chatbots usage, perceived risks and benefits among physicians has evolved over time and their impact on clinical and academic activities remain unclear. The aim of this study is to assess how the use of GPTs/LLMs chatbots by professionals working in urology has changed over time in the setting of academic and clinical activities.

Authors

  • Francesco Cei
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Conner Ganjavi
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Ethan Layne
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Tesniem Hussari
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Rafael R Gevorkyan
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Michael Eppler
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Pietro Piazza
    Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Severin Rodler
    Department of Urology, Klinikum der Universitaet Muenchen, Munich, Germany.
  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Juan Gomez Rivas
    Department of Urology, Clinico San Carlos University Hospital, Madrid, Spain.
  • Karl F Kowalewski
    Department of Urology, University Medical Center Mannheim, Heidelberg University, Heidelberg, Germany.
  • Ines Rivero Belenchón
    Urology and Nephrology Department, Virgen del Rocío University Hospital, Seville, Spain.
  • Stefano Puliatti
    Urology Department, University of Modena and Reggio Emilia, Modena, Italy.
  • Mark Taratkin
    Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Alessandro Veccia
    Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Loïc Baekelandt
    Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Pieter De Backer
    ORSI Academy Melle Belgium.
  • Jeremy Teoh
    S.H. Ho Urology Center, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Bhaskar Somani
    Department of Urology, University of Southampton, Southampton, United Kingdom.
  • Marcelo Wroclawski
    Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Andre DE Castro Abreu
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Alberto Briganti
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Andrea Salonia
    Department of Urology, IRCCS San Raffaele Scientific Institute - Vita-Salute San Raffaele University, Milan, Italy.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Declan Murphy
    Sir Peter MacCallum Department of Surgical Oncology, University of Melbourne, 305 Grattan Street, Melbourne, Australia.
  • David Canes
    Lahey Institute of Urology, Lahey Hospital & Medical Center, Beth Israel and Lahey Health, Burlington, MA, United States.
  • Inderbir Gill
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Giovanni E Cacciamani
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA - giovanni.cacciamani@med.usc.edu.

Keywords

No keywords available for this article.